Inhibitory effects of human sera on adenovirus-mediated gene transfer into rat liver. 1998

S Kuriyama, and K Tominaga, and M Kikukawa, and T Nakatani, and H Tsujinoue, and M Yamazaki, and S Nagao, and Y Toyokawa, and A Mitoro, and H Fukui
Third Department of Internal Medicine, Nara Medical University, Japan.

Recent advances in molecular biology have made gene therapy for cancer feasible in clinical trials. Although recombinant adenovirus is an attractive vehicle for transferring therapeutic genes in vivo, animal studies have indicated that the clinical usefulness of adenovirus vectors may be limited by their immunogenicity. It has been shown that neutralizing antibodies against adenoviruses reduce the efficiency of vector readministration. It is of great importance to examine the effects of human sera on adenovirus-mediated gene transfer, because the majority of prospective gene therapy patients are likely to have been exposed to wild-type adenoviruses. In the present study, it was shown that anti-adenovirus antibody-positive human sera with the lowest positive titer substantially inhibit the adenovirus-mediated gene transfer not only in vitro but also in vivo. These results may have important implications for efficacy considerations when adenovirus vectors are employed in the clinical setting.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005260 Female Females
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

S Kuriyama, and K Tominaga, and M Kikukawa, and T Nakatani, and H Tsujinoue, and M Yamazaki, and S Nagao, and Y Toyokawa, and A Mitoro, and H Fukui
June 2005, World journal of gastroenterology,
S Kuriyama, and K Tominaga, and M Kikukawa, and T Nakatani, and H Tsujinoue, and M Yamazaki, and S Nagao, and Y Toyokawa, and A Mitoro, and H Fukui
July 1997, Molecular and cellular biochemistry,
S Kuriyama, and K Tominaga, and M Kikukawa, and T Nakatani, and H Tsujinoue, and M Yamazaki, and S Nagao, and Y Toyokawa, and A Mitoro, and H Fukui
March 1998, Current eye research,
S Kuriyama, and K Tominaga, and M Kikukawa, and T Nakatani, and H Tsujinoue, and M Yamazaki, and S Nagao, and Y Toyokawa, and A Mitoro, and H Fukui
April 1995, Journal of molecular medicine (Berlin, Germany),
S Kuriyama, and K Tominaga, and M Kikukawa, and T Nakatani, and H Tsujinoue, and M Yamazaki, and S Nagao, and Y Toyokawa, and A Mitoro, and H Fukui
December 1995, Brain research. Molecular brain research,
S Kuriyama, and K Tominaga, and M Kikukawa, and T Nakatani, and H Tsujinoue, and M Yamazaki, and S Nagao, and Y Toyokawa, and A Mitoro, and H Fukui
January 2001, Transplantation proceedings,
S Kuriyama, and K Tominaga, and M Kikukawa, and T Nakatani, and H Tsujinoue, and M Yamazaki, and S Nagao, and Y Toyokawa, and A Mitoro, and H Fukui
September 1993, Biochemical and biophysical research communications,
S Kuriyama, and K Tominaga, and M Kikukawa, and T Nakatani, and H Tsujinoue, and M Yamazaki, and S Nagao, and Y Toyokawa, and A Mitoro, and H Fukui
January 1994, Transplantation,
S Kuriyama, and K Tominaga, and M Kikukawa, and T Nakatani, and H Tsujinoue, and M Yamazaki, and S Nagao, and Y Toyokawa, and A Mitoro, and H Fukui
January 2009, Journal of virology,
S Kuriyama, and K Tominaga, and M Kikukawa, and T Nakatani, and H Tsujinoue, and M Yamazaki, and S Nagao, and Y Toyokawa, and A Mitoro, and H Fukui
April 1996, Gene therapy,
Copied contents to your clipboard!